New Trends in Parathyroid Surgery

Current Problems in Surgery

Volumn 47, Issue 12, 2010, Pages 958-1017

  Adler, Joel T ^a   Sippel, Rebecca S ^b   Chen, Herbert ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BISPHOSPHONIC ACID DERIVATIVE; CALCIFEDIOL; CALCIMIMETIC AGENT; CALCITONIN; CALCIUM; CINACALCET; COLLAGEN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; FLUOROURACIL; GLUCOCORTICOID; HYDROXYAPATITE; LOMUSTINE; LOOP DIURETIC AGENT; METHOTREXATE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; MITHRAMYCIN; PARATHYROID HORMONE; PERTECHNETIC ACID TC 99M; PHOSPHATE BINDING AGENT; RADIESSE VOICE; RALOXIFENE; THALLIUM 201; UNCLASSIFIED DRUG; VITAMIN D;

ABLATION THERAPY; ARTHRALGIA; ARTICLE; AUTOTRANSPLANTATION; BLEEDING; BONE DENSITY; CANCER IMMUNOTHERAPY; CLINICAL DECISION MAKING; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIARRHEA; DISEASE SEVERITY; DRUG MECHANISM; ECHOGRAPHY; ECTOPIC ORGAN; ELDERLY CARE; FAMILIAL DISEASE; FAMILIAL HYPOCALCIURIC HYPOCALCEMIA; FRACTURE; GENERAL ANESTHESIA; HEMATOMA; HISTOPATHOLOGY; HOARSENESS; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; HYPOCALCEMIA; HYPOPARATHYROIDISM; LEGAL ASPECT; LOCAL ANESTHESIA; LOW DRUG DOSE; MEDICAL ETHICS; METASTASIS; MINIMALLY INVASIVE SURGERY; MULTIPLE ENDOCRINE NEOPLASIA; MYALGIA; NAUSEA; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARATHYROID CARCINOMA; PARATHYROID DISEASE; PARATHYROID FUNCTION; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; PEROPERATIVE CARE; PREDICTION; PREGNANCY; PREOPERATIVE EVALUATION; PREVALENCE; PRIMARY HYPERPARATHYROIDISM; QUALITY OF LIFE; RECURRENT DISEASE; RECURRENT LARYNGEAL NERVE PALSY; REOPERATION; RESPIRATORY TRACT INFECTION; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SECONDARY HYPERPARATHYROIDISM; SIDE EFFECT; SINGLE DRUG DOSE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SIPPLE SYNDROME; SURGICAL APPROACH; SURGICAL TECHNIQUE; TREATMENT INDICATION; TREATMENT PLANNING; TREND STUDY; UROLITHIASIS; VITAMIN D DEFICIENCY;

AGE FACTORS; COST-BENEFIT ANALYSIS; DIAGNOSIS, DIFFERENTIAL; HUMANS; HYPERPARATHYROIDISM, PRIMARY; HYPERPARATHYROIDISM, SECONDARY; PARATHYROID NEOPLASMS; PARATHYROIDECTOMY; PATIENT SATISFACTION; PRACTICE GUIDELINES AS TOPIC; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; RISK FACTORS; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TREATMENT OUTCOME;

EID: 78049302212     PISSN: 00113840     EISSN: None     Source Type: Journal    
DOI: 10.1067/j.cpsurg.2010.08.002     Document Type: Article

References (201)

1. Coker L.H., Rorie K., Cantley L., et al. Primary hyperparathyroidism, cognition, and health-related quality of life. Ann Surg 2005, 242(5):642-650.
2. Modarai B., Sawyer A., Ellis H. The glands of Owen. J R Soc Med 2004, 97(10):494-495.
3. Owen R. The life of Richard Owen 1894, D Appleton, New York.
4. Owen R. On the anatomy of the Indian Rhinocerous. Trans Zool Soc Lond 1862, 4:31-58.
5. Sandström I.V. En ny körtel hos menniskan och åtskilliga däggdjur. Ups Läk Förh 1880, 15:441-471.
6. Carney J.A. The glandulae parathyroideae of Ivar Sandstrom. Contributions from two continents. Am J Surg Pathol 1996, 20(9):1123-1144.
7. Mandl F. Hyperparathyroidism. A review of historical developments and the present state of knowledge on the subject. Recent Adv Surg 1947, 21:374-439.
8. Kronenberg H., Williams R.H. Williams Textbook of Endocrinology 2008, Saunders/Elsevier, Philadelphia. 11th edition.
9. Akerstrom G., Malmaeus J., Bergstrom R. Surgical anatomy of human parathyroid glands. Surgery 1984, 95(1):14-21.
10. Kumar V., Abbas A.K., Fausto N. Robbins and Cotran Pathologic Basis of Disease 2005, Elsevier/WB Saunders, Philadelphia. 7th edition.
11. Adler J.T., Sippel R.S., Schaefer S., et al. Preserving function and quality of life after thyroid and parathyroid surgery. Lancet Oncol 2008, 9(11):1069-1075.
12. Heyliger A., Tangpricha V., Weber C., et al. Parathyroidectomy decreases systolic and diastolic blood pressure in hypertensive patients with primary hyperparathyroidism. Surgery 2009, 146(6):1042-1047.
13. Rubin M.R., Bilezikian J.P., McMahon D.J., et al. The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. J Clin Endocrinol Metab 2008, 93(9):3462-3470.
14. Silverberg S.J., Shane E., Jacobs T.P., et al. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med 1999, 341(17):1249-1255.
15. Bilezikian J.P., Khan A.A., Potts J.T. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab 2009, 94(2):335-339.
16. Silverberg S.J., Lewiecki E.M., Mosekilde L., et al. Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab 2009, 94(2):351-365.
17. Eastell R., Arnold A., Brandi M.L., et al. Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab 2009, 94(2):340-350.
18. Udelsman R., Pasieka J.L., Sturgeon C., et al. Surgery for asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab 2009, 94(2):366-372.
19. Ambrogini E., Cetani F., Cianferotti L., et al. Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial. J Clin Endocrinol Metab 2007, 92(8):3114-3121.
20. Carneiro-Pla D.M., Irvin G.L., Chen H. Consequences of parathyroidectomy in patients with "mild" sporadic primary hyperparathyroidism. Surgery 2007, 142(6):795-799. Discussion 799, e791-2.
21. Goasguen N., Chirica M., Roger N., et al. Primary hyperparathyroidism from parathyroid microadenoma: specific features and implications for a surgical strategy in the era of minimally invasive parathyroidectomy. J Am Coll Surg 2010, 210(4):456-462.
22. Ariyan C.E., Sosa J.A. Assessment and management of patients with abnormal calcium. Crit Care Med 2004, 32(4(suppl):S146-S154.
23. Lew J.I., Solorzano C.C., Irvin G.L. Long-term results of parathyroidectomy for hypercalcemic crisis. Arch Surg 2006, 141(7):696-699.
24. Pitt S.C., Sippel R.S., Chen H. Secondary and tertiary hyperparathyroidism, state of the art surgical management. Surg Clin North Am 2009, 89(5):1227-1239.
25. Triponez F., Clark O.H., Vanrenthergem Y., et al. Surgical treatment of persistent hyperparathyroidism after renal transplantation. Ann Surg 2008, 248(1):18-30.
26. Milas M., Weber C.J. Near-total parathyroidectomy is beneficial for patients with secondary and tertiary hyperparathyroidism. Surgery 2004, 136(6):1252-1260.
27. Shen W.T., Kebebew E., Suh I., et al. Two hundred and two consecutive operations for secondary hyperparathyroidism: has medical management changed the profiles of patients requiring parathyroidectomy?. Surgery 2009, 146(2):296-299.
28. Kerby J.D., Rue L.W., Blair H., et al. Operative treatment of tertiary hyperparathyroidism: a single-center experience. Ann Surg 1998, 227(6):878-886.
29. Pitt S.C., Panneerselvan R., Chen H., et al. Tertiary hyperparathyroidism: is less than a subtotal resection ever appropriate?. A study of long-term outcomes. Surgery 2009, 146(6):1130-1137.
30. Shattuck T.M., Valimaki S., Obara T., et al. Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med 2003, 349(18):1722-1729.
31. Lee P.K., Jarosek S.L., Virnig B.A., et al. Trends in the incidence and treatment of parathyroid cancer in the United States. Cancer 2007, 109(9):1736-1741.
32. Ware J.E., Sherbourne C.D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992, 30(6):473-483.
33. McHorney C.A., Ware J.E., Lu J.F., et al. The MOS 36 -item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994, 32(1):40-66.
34. Pasieka J.L., Parsons L.L., Demeure M.J., et al. Patient-based surgical outcome tool demonstrating alleviation of symptoms following parathyroidectomy in patients with primary hyperparathyroidism. World J Surg 2002, 26(8):942-949.
35. Mihai R., Sadler G.P. Pasieka's parathyroid symptoms scores correlate with SF-36 scores in patients undergoing surgery for primary hyperparathyroidism. World J Surg 2008, 32:807-814.
36. Sheldon D.G., Lee F.T., Neil N.J., et al. Surgical treatment of hyperparathyroidism improves health-related quality of life. Arch Surg 2002, 137(9):1022-1026. Discussion 1026-8.
37. Greutelaers B., Kullen K., Kollias J., et al. Pasieka Illness Questionnaire: its value in primary hyperparathyroidism. Aust NZ J Surg 2004, 74(3):112-115.
38. Edwards M.E., Rotramel A., Beyer T., et al. Improvement in the health-related quality-of-life symptoms of hyperparathyroidism is durable on long-term follow-up. Surgery 2006, 140(4):655-663. Discussion 653-4.
39. Pasieka J.L., Parsons L., Jones J. The long-term benefit of parathyroidectomy in primary hyperparathyroidism: a 10-year prospective surgical outcome study. Surgery 2009, 146(6):1006-1013.
40. Politz D., Livingston C.D., Victor B., et al. Minimally invasive radio-guided parathyroidectomy in 152 consecutive patients with primary hyperparathyroidism. Endocr Pract 2006, 12(6):630-634.
41. Chen H., Sokoll L.J., Udelsman R. Outpatient minimally invasive parathyroidectomy: a combination of sestamibi-SPECT localization, cervical block anesthesia, and intraoperative parathyroid hormone assay. Surgery 1999, 126(6):1016-1021. Discussion 1021-12.
42. Adler J.T., Sippel R.S., Chen H. The influence of surgical approach on quality of life after parathyroid surgery. Ann Surg Oncol 2008, 15(6):1559-1565.
43. Barczynski M., Cichon S., Konturek A., et al. Minimally invasive video-assisted parathyroidectomy versus open minimally invasive parathyroidectomy for a solitary parathyroid adenoma: a prospective, randomized, blinded trial. World J Surg 2006, 30(5):721-731.
44. Bollerslev J., Jansson S., Mollerup C.L., et al. Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial. J Clin Endocrinol Metab 2007, 92(5):1687-1692.
45. Tsukahara K., Sugitani I., Fujimoto Y., et al. Surgery did not improve the subjective neuropsychological symptoms of patients with incidentally detected mild primary hyperparathyroidism. Eur Arch Otorhinolaryngol 2008, 265:565-569. [Epub Nov 14 2007].
46. Rao D.S., Phillips E.R., Divine G.W., et al. Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. J Clin Endocrinol Metab 2004, 89(11):5415-5422.
47. Eigelberger M.S., Cheah W.K., Ituarte P.H., et al. Criteria for parathyroidectomy in asymptomatic primary hyperparathyroidism: are they too limited?. Ann Surg 2004, 239(4):528-535.
48. Talpos G.B., Bone H.G., Kleerekoper M., et al. Randomized trial of parathyroidectomy in mild asymptomatic primary hyperparathyroidism: patient description and effects on the SF-36 health survey. Surgery 2000, 128(6):1013-1020. Discussion 1020-11.
49. Sejean K., Calmus S., Durand-Zaleski I., et al. Surgery versus medical follow-up in patients with asymptomatic primary hyperparathyroidism: a decision analysis. Eur J Endocrinol 2005, 153(6):915-927.
50. Zanocco K., Angelos P., Sturgeon C. Cost-effectiveness analysis of parathyroidectomy for asymptomatic primary hyperparathyroidism. Surgery 2006, 140(6):874-881. Discussion 881-72.
51. Pruhs Z.M., Starling J.R., Mack E., et al. Changing trends for surgery in elderly patients with hyperparathyroidism at a single institution. J Surg Res 2005, 127(1):58-62.
52. Chiba Y., Satoh K., Ueda S., et al. Marked improvement of psychiatric symptoms after parathyroidectomy in elderly primary hyperparathyroidism. Endocr J 2007, 54(3):379-383.
53. Egan K.R., Adler J.T., Olson J.E., et al. Parathyroidectomy for primary hyperparathyroidism in octogenarians and nonagenarians: a risk-benefit analysis. J Surg Res 2007, 140(2):194-198.
54. Chen H., Parkerson S., Udelsman R. Parathyroidectomy in the elderly: do the benefits outweigh the risks?. World J Surg 1998, 22(6):531-535. Discussion 535-6.
55. Morris G.S., Grubbs E.G., Hearon C.M., et al. Parathyroidectomy improves functional capacity in "asymptomatic" older patients with primary hyperparathyroidism: a randomized control trial. Ann Surg 2010, 251:832-837.
56. Zanocco K., Sturgeon C. How should age at diagnosis impact treatment strategy in asymptomatic primary hyperparathyroidism?. A cost-effectiveness analysis. Surgery 2008, 144(2):290-298.
57. Doherty D.B., Mittendorf E.A., Valentine A.D., et al. An elderly woman with primary hyperparathyroidism exhibits improvement of neurocognitive dysfunction after parathyroidectomy. J Am Geriatr Soc 2007, 55(10):1689-1691.
58. Roman S., Sosa J.A. Psychiatric and cognitive aspects of primary hyperparathyroidism. Curr Opin Oncol 2007, 19(1):1-5.
59. Roman S.A., Sosa J.A., Mayes L., et al. Parathyroidectomy improves neurocognitive deficits in patients with primary hyperparathyroidism. Surgery 2005, 138(6):1121-1128. Discussion 1128-9.
60. Mittendorf E.A., Wefel J.S., Meyers C.A., et al. Improvement of sleep disturbance and neurocognitive function after parathyroidectomy in patients with primary hyperparathyroidism. Endocr Pract 2007, 13(4):338-344.
61. Adler J.T., Sippel R.S., Schaefer S., et al. Surgery improves quality of life in patients with "mild" hyperparathyroidism. Am J Surg 2009, 197(3):284-290.
62. Repplinger D., Schaefer S., Chen H., et al. Neurocognitive dysfunction: a predictor of parathyroid hyperplasia. Surgery 2009, 146(6):1138-1143.
63. Pasieka J.L., Parsons L.L. A prospective surgical outcome study assessing the impact of parathyroidectomy on symptoms in patients with secondary and tertiary hyperparathyroidism. Surgery 2000, 128(4):531-539.
64. Sambrook P.N., Chen J.S., March L.M., et al. Serum parathyroid hormone is associated with increased mortality independent of 25-hydroxy vitamin d status, bone mass, and renal function in the frail and very old: a cohort study. J Clin Endocrinol Metab 2004, 89(11):5477-5481.
65. VanderWalde L.H., Liu I.L., O'Connell T.X., et al. The effect of parathyroidectomy on bone fracture risk in patients with primary hyperparathyroidism. Arch Surg 2006, 141(9):885-889.
66. Lowe H., McMahon D.J., Rubin M.R., et al. Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype. J Clin Endocrinol Metab 2007, 92(8):3001-3005.
67. Leopaldi E., Paolino L.A., Bevilacqua M., et al. Prediction of bone mass gain by bone turnover parameters after parathyroidectomy for primary hyperparathyroidism: neural network software statistical analysis. Surgery 2006, 139(6):827-832.
68. Alley R.A., Chen E.L., Beyer T.D., et al. Does homocysteine contribute to bone disease in hyperparathyroidism?. Am J Surg 2008, 195(3):374-377.
69. Mihai R., Simon D., Hellman P. Imaging for primary hyperparathyroidism-an evidence-based analysis. Langenbecks Arch Surg 2009, 394(5):765-784.
70. Gotthardt M., Lohmann B., Behr T.M., et al. Clinical value of parathyroid scintigraphy with technetium-99m methoxyisobutylisonitrile: discrepancies in clinical data and a systematic metaanalysis of the literature. World J Surg 2004, 28(1):100-107.
71. Prommegger R., Wimmer G., Profanter C., et al. Virtual neck exploration: a new method for localizing abnormal parathyroid glands. Ann Surg 2009, 250(5):761-765.
72. Heizmann O., Viehl C.T., Schmid R., et al. Impact of concomitant thyroid pathology on preoperative workup for primary hyperparathyroidism. Eur J Med Res 2009, 14(1):37-41.
73. Gates J.D., Benavides L.C., Shriver C.D., et al. Preoperative thyroid ultrasound in all patients undergoing parathyroidectomy?. J Surg Res 2009, 155(2):254-260.
74. Erbil Y., Barbaros U., Yanik B.T., et al. Impact of gland morphology and concomitant thyroid nodules on preoperative localization of parathyroid adenomas. Laryngoscope 2006, 116(4):580-585.
75. Gilat H., Cohen M., Feinmesser R., et al. Minimally invasive procedure for resection of a parathyroid adenoma: the role of preoperative high-resolution ultrasonography. J Clin Ultrasound 2005, 33(6):283-287.
76. Solorzano C.C., Carneiro-Pla D.M., Irvin G.L. Surgeon-performed ultrasonography as the initial and only localizing study in sporadic primary hyperparathyroidism. J Am Coll Surg 2006, 202(1):18-24.
77. Ruda J.M., Stack B.C., Hollenbeak C.S. The cost-effectiveness of additional preoperative ultrasonography or sestamibi-SPECT in patients with primary hyperparathyroidism and negative findings on sestamibi scans. Arch Otolaryngol Head Neck Surg 2006, 132(1):46-53.
78. Tublin M.E., Pryma D.A., Yim J.H., et al. Localization of parathyroid adenomas by sonography and technetium Tc99m sestamibi single-photon emission computed tomography before minimally invasive parathyroidectomy: are both studies really needed?. J Ultrasound Med 2009, 28(2):183-190.
79. Smith N., Magnuson J.S., Vidrine D.M., et al. Minimally invasive parathyroidectomy: use of intraoperative parathyroid hormone assays after 2 preoperative localization studies. Arch Otolaryngol Head Neck Surg 2009, 135(11):1108-1111.
80. Ito F., Sippel R., Lederman J., et al. The utility of intraoperative bilateral internal jugular venous sampling with rapid parathyroid hormone testing. Ann Surg 2007, 245(6):959-963.
81. Randall G.J., Zald P.B., Cohen J.I., et al. Contrast-enhanced MDCT characteristics of parathyroid adenomas. AJR Am J Roentgenol Aug 2009, 193(2):W139-W143.
82. Zald P.B., Hamilton B.E., Larsen M.L., et al. The role of computed tomography for localization of parathyroid adenomas. Laryngoscope 2008, 118(8):1405-1410.
83. Abikhzer G., Levental M., Rush C. High resolution MRI in the detection of an intrathymic parathyroid adenoma. Br J Radiol 2006, 79(945):e78-e80.
84. Yen T.W., Wang T.S., Doffek K.M., et al. Reoperative parathyroidectomy: an algorithm for imaging and monitoring of intraoperative parathyroid hormone levels that results in a successful focused approach. Surgery 2008, 144(4):611-619. Discussion 619-21.
85. Rodgers S.E., Hunter G.J., Hamberg L.M., et al. Improved preoperative planning for directed parathyroidectomy with 4-dimensional computed tomography. Surgery 2006, 140(6):932-940. Discussion 940-31.
86. Lorberboym M., Ezri T., Schachter P.P. Preoperative technetium Tc99m sestamibi SPECT imaging in the management of primary hyperparathyroidism in patients with concomitant multinodular goiter. Arch Surg 2005, 140(7):656-660.
87. Sippel R.S., Bianco J., Wilson M., et al. Can thallium-pertechnetate subtraction scanning play a role in the preoperative imaging for minimally invasive parathyroidectomy?. Clin Nucl Med 2004, 29(1):21-26.
88. Frydman J., Bianco J., Drezner M., et al. Thallium-pertechnetate subtraction scanning in the preoperative localization of an ectopic undescended parathyroid gland. Clin Nucl Med 2004, 29(9):542-544.
89. Carneiro-Pla D. Effectiveness of "office"-based, ultrasound-guided differential jugular venous sampling (DJVS) of parathormone in patients with primary hyperparathyroidism. Surgery 2009, 146(6):1014-1020.
90. Chen H. Radioguided parathyroid surgery. Adv Surg 2004, 38:377-392.
91. Snyder S.K., Roberson C.R., Cummings C.C., et al. Local anesthesia with monitored anesthesia care vs general anesthesia in thyroidectomy: a randomized study. Arch Surg 2006, 141(2):167-173.
92. Barczynski M., Konturek A., Hubalewska-Dydejczyk A., et al. Evaluation of Halle, Miami, Rome, and Vienna intraoperative iPTH assay criteria in guiding minimally invasive parathyroidectomy. Langenbecks Arch Surg 2009, 394(5):843-849.
93. Cook M.R., Pitt S.C., Schaefer S., et al. A rising ioPTH level immediately after parathyroid resection: are additional hyperfunctioning glands always present?. An application of the Wisconsin criteria. Ann Surg 2010, 251(6):1127-1130.
94. Chen H., Mack E., Starling J.R. A comprehensive evaluation of perioperative adjuncts during minimally invasive parathyroidectomy: which is most reliable?. Ann Surg 2005, 242(3):375-380.
95. Wineland A., Siegel E., Stack B.C. Reexamining normative radiation data for radioguided parathyroid surgery. Arch Otolaryngol Head Neck Surg 2008, 134(11):1209-1213.
96. Norman J., Chheda H. Minimally invasive parathyroidectomy facilitated by intraoperative nuclear mapping. Surgery 1997, 122(6):998-1003. Discussion 1003-4.
97. Mariani G., Gulec S.A., Rubello D., et al. Preoperative localization and radioguided parathyroid surgery. J Nucl Med 2003, 44(9):1443-1458.
98. Hessman O., Westerdahl J., Al-Suliman N., et al. Randomized clinical trial comparing open with video-assisted minimally invasive parathyroid surgery for primary hyperparathyroidism. Br J Surg 2010, 97(2):177-184.
99. Casserly P., Kirby R., Timon C. Outcome measures and scar aesthetics in minimally invasive video-assisted parathyroidectomy. Arch Otolaryngol Head Neck Surg 2010, 136(3):260-264.
100. Gasparri G., Camandona M., Bertoldo U., et al. The usefulness of preoperative dual-phase 99mTc MIBI-scintigraphy and IO-PTH assay in the treatment of secondary and tertiary hyperparathyroidism. Ann Surg 2009, 250(6):868-871.
101. Nichol P.F., Starling J.R., Mack E., et al. Long-term follow-up of patients with tertiary hyperparathyroidism treated by resection of a single or double adenoma. Ann Surg 2002, 235(5):673-678. Discussion 678-80.
102. Rothmund M., Wagner P.K., Schark C. Subtotal parathyroidectomy versus total parathyroidectomy and autotransplantation in secondary hyperparathyroidism: a randomized trial. World J Surg 1991, 15(6):745-750.
103. Schlosser K., Veit J.A., Witte S., et al. Comparison of total parathyroidectomy without autotransplantation and without thymectomy versus total parathyroidectomy with autotransplantation and with thymectomy for secondary hyperparathyroidism: TOPAR PILOT-trial. Trials 2007, 8:22.
104. Pitt S.C., Panneerselvan R., Chen H., et al. Secondary and tertiary hyperparathyroidism: the utility of ioPTH monitoring. World J Surg 2010, 34:343-349.
105. Sippel R.S., Bianco J., Chen H. Radioguided parathyroidectomy for recurrent hyperparathyroidism caused by forearm graft hyperplasia. J Bone Miner Res 2003, 18(5):939-942.
106. Weigel T.L., Murphy J., Kabbani L., et al. Thoracoscopic mediastinal parathyroidectomy with intraoperative parathyroid hormone testing. Ann Thorac Surg 2005, 80(4):1262-1265.
107. Braumann C., Jacobi C.A., Menenakos C., et al. Robotic-assisted laparoscopic and thoracoscopic surgery with the da Vinci system: a 4-year experience in a single institution. Surg Laparosc Endosc Percutan Tech 2008, 18(3):260-266.
108. Callender G.G., Rich T.A., Perrier N.D. Multiple endocrine neoplasia syndromes. Surg Clin North Am 2008, 88(4):863-895. viii.
109. Mutch M.G., Dilley W.G., Sanjurjo F., et al. Germline mutations in the multiple endocrine neoplasia type 1 gene: evidence for frequent splicing defects. Hum Mutat 1999, 13(3):175-185.
110. Trump D., Farren B., Wooding C., et al. Clinical studies of multiple endocrine neoplasia type 1 (MEN1). QJM Sept 1996, 89(9):653-669.
111. Brandi M.L., Gagel R.F., Angeli A., et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 2001, 86(12):5658-5671.
112. Kelly T.G., Shattuck T.M., Reyes-Mugica M., et al. Surveillance for early detection of aggressive parathyroid disease: carcinoma and atypical adenoma in familial isolated hyperparathyroidism associated with a germline HRPT2 mutation. J Bone Miner Res 2006, 21(10):1666-1671.
113. Lal A., Bianco J., Chen H. Radioguided parathyroidectomy in patients with familial hyperparathyroidism. Ann Surg Oncol 2007, 14(2):739-743.
114. Elaraj D.M., Skarulis M.C., Libutti S.K., et al. Results of initial operation for hyperparathyroidism in patients with multiple endocrine neoplasia type 1. Surgery 2003, 134(6):858-864. Discussion 864-55.
115. Santoro M., Carlomagno F., Melillo R.M., et al. Dysfunction of the RET receptor in human cancer. Cell Mol Life Sci 2004, 61(23):2954-2964.
116. Eng C., Clayton D., Schuffenecker I., et al. The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. JAMA 1996, 276(19):1575-1579.
117. Gertner M.E., Kebebew E. Multiple endocrine neoplasia type 2. Curr Treat Options Oncol 2004, 5(4):315-325.
118. Skinner M.A., Moley J.A., Dilley W.G., et al. Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A. N Engl J Med 2005, 353(11):1105-1113.
119. Sarquis M.S., Silveira L.G., Pimenta F.J., et al. Familial hyperparathyroidism: surgical outcome after 30 years of follow-up in three families with germline HRPT2 mutations. Surgery 2008, 143(5):630-640.
120. Warner J.V., Nyholt D.R., Busfield F., et al. Familial isolated hyperparathyroidism is linked to a 1.7 Mb region on chromosome 2p13.3-14. J Med Genet 2006, 43(3):e12.
121. Marx S.J., Simonds W.F., Agarwal S.K., et al. Hyperparathyroidism in hereditary syndromes: special expressions and special managements. J Bone Miner Res 2002, 17(suppl 2):N37-N43.
122. Pallais J.C., Kifor O., Chen Y.B., et al. Acquired hypocalciuric hypercalcemia due to autoantibodies against the calcium-sensing receptor. N Engl J Med 2004, 351(4):362-369.
123. Lietman S.A., Tenenbaum-Rakover Y., Jap T.S., et al. A novel loss-of-function mutation, Gln459Arg, of the calcium-sensing receptor gene associated with apparent autosomal recessive inheritance of familial hypocalciuric hypercalcemia. J Clin Endocrinol Metab 2009, 94(11):4372-4379.
124. Raue F., Haag C., Schulze E., et al. The role of the extracellular calcium-sensing receptor in health and disease. Exp Clin Endocrinol Diabetes 2006, 114(8):397-405.
125. Marx S.J., Attie M.F., Levine M.A., et al. The hypocalciuric or benign variant of familial hypercalcemia: clinical and biochemical features in fifteen kindreds. Medicine Baltimore 1981, 60(6):397-412.
126. Marx S.J., Attie M.F., Spiegel A.M., et al. An association between neonatal severe primary hyperparathyroidism and familial hypocalciuric hypercalcemia in three kindreds. N Engl J Med 1982, 306(5):257-264.
127. Timmers H.J., Karperien M., Hamdy N.A., et al. Normalization of serum calcium by Cinacalcet in a patient with hypercalcaemia due to a de novo inactivating mutation of the calcium-sensing receptor. J Intern Med 2006, 260(2):177-182.
128. Rodgers S.E., Perrier N.D. Parathyroid carcinoma. Curr Opin Oncol 2006, 18(1):16-22.
129. Arslan N., Rydzewski B. Detection of a recurrent parathyroid carcinoma with FDG positron emission tomography. Clin Nucl Med 2002, 27(3):221-222.
130. Boyle N.H., Ogg C.S., Hartley R.B., et al. Parathyroid carcinoma secondary to prolonged hyperplasia in chronic renal failure and in coeliac disease. Eur J Surg Oncol 1999, 25(1):100-103.
131. Krebs L.J., Shattuck T.M., Arnold A. HRPT2 mutational analysis of typical sporadic parathyroid adenomas. J Clin Endocrinol Metab 2005, 90(9):5015-5017.
132. Placzkowski K., Christian R., Chen H. Radioguided parathyroidectomy for recurrent parathyroid cancer. Clin Nucl Med 2007, 32(5):358-360.
133. DeLellis R.A., Mazzaglia P., Mangray S. Primary hyperparathyroidism: a current perspective. Arch Pathol Lab Med 2008, 132(8):1251-1262.
134. Dong B.J. Cinacalcet: an oral calcimimetic agent for the management of hyperparathyroidism. Clin Ther 2005, 27(11):1725-1751.
135. Bukowski R.M., Sheeler L., Cunningham J., et al. Successful combination chemotherapy for metastatic parathyroid carcinoma. Arch Intern Med 1984, 144(2):399-400.
136. Busaidy N.L., Jimenez C., Habra M.A., et al. Parathyroid carcinoma: a 22-year experience. Head Neck 2004, 26(8):716-726.
137. Rawat N., Khetan N., Williams D.W., et al. Parathyroid carcinoma. Br J Surg 2005, 92(11):1345-1353.
138. Howell V.M., Gill A., Clarkson A., et al. Accuracy of combined protein gene product 9.5 and parafibromin markers for immunohistochemical diagnosis of parathyroid carcinoma. J Clin Endocrinol Metab 2009, 94(2):434-441.
139. Abdelgadir A.M., Untch B.R., Olson J.A. Parathyroid carcinoma: current understanding and new insights into gene expression and intraoperative parathyroid hormone kinetics. Oncologist 2010, 15(1):61-72.
140. Hwang R.S., Morris L.F., Ro K., et al. A selective, Bayesian approach to intraoperative PTH monitoring. Ann Surg 2010, 251(6):1122-1126.
141. Chen H., Sippel R.S., Schaefer S. The effectiveness of radioguided parathyroidectomy in patients with negative technetium Tc99m-sestamibi scans. Arch Surg 2009, 144(7):643-648.
142. Rubello D., Piotto A., Pagetta C., et al. Ectopic parathyroid adenomas located at the carotid bifurcation: the role of preoperative Tc-99m MIBI scintigraphy and the intraoperative gamma probe procedure in surgical treatment planning. Clin Nucl Med 2001, 26(9):774-776.
143. Harari A., Zarnegar R., Lee J., et al. Computed tomography can guide focused exploration in select patients with primary hyperparathyroidism and negative sestamibi scanning. Surgery 2008, 144(6):970-976. Discussion 976-9.
144. Caron N.R., Sturgeon C., Clark O.H. Persistent and recurrent hyperparathyroidism. Curr Treat Options Oncol 2004, 5(4):335-345.
145. Richards M.L., Thompson G.B., Farley D.R., et al. Reoperative parathyroidectomy in 228 patients during the era of minimal-access surgery and intraoperative parathyroid hormone monitoring. Am J Surg 2008, 196(6):937-942. Discussion 942-33.
146. Powell A.C., Alexander H.R., Chang R., et al. Reoperation for parathyroid adenoma: a contemporary experience. Surgery 2009, 146(6):1144-1155.
147. Schnatz P.F., Curry S.L. Primary hyperparathyroidism in pregnancy: evidence-based management. Obstet Gynecol Surv 2002, 57(6):365-376.
148. Shani H., Sivan E., Cassif E., et al. Maternal hypercalcemia as a possible cause of unexplained fetal polyhydramnion: a case series. Am J Obstet Gynecol 2008, 199(4):410. e411-5.
149. Norman J., Politz D., Politz L. Hyperparathyroidism during pregnancy and the effect of rising calcium on pregnancy loss: a call for earlier intervention. Clin Endocrinol 2009, 71(1):104-109.
150. Hultin H., Hellman P., Lundgren E., et al. Association of parathyroid adenoma and pregnancy with preeclampsia. J Clin Endocrinol Metab 2009, 94(9):3394-3399.
151. McMullen T.P., Learoyd D.L., Williams D.C., et al. Hyperparathyroidism in pregnancy: options for localization and surgical therapy. World J Surg 2010, 34:1811-1816.
152. Dincer S.I., Demir A., Kara H.V., et al. Thoracoscopic removal of a maternal mediastinal ectopic parathyroid adenoma causing neonatal hypocalcemia: a case report. Ann Thorac Cardiovasc Surg 2008, 14(5):325-328.
153. Mallet E. Primary hyperparathyroidism in neonates and childhood. The French experience (1984-2004). Horm Res 2008, 69(3):180-188.
154. Kollars J., Zarroug A.E., van Heerden J., et al. Primary hyperparathyroidism in pediatric patients. Pediatrics 2005, 115(4):974-980.
155. Ali F.N., Arguelles L.M., Langman C.B., et al. Vitamin D deficiency in children with chronic kidney disease: uncovering an epidemic. Pediatrics 2009, 123(3):791-796.
156. Seeherunvong W., Abitbol C.L., Chandar J., et al. Vitamin D insufficiency and deficiency in children with early chronic kidney disease. J Pediatr 2009, 154(6):906-911.e1.
157. Kievit A.J., Tinnemans J.G., Idu M.M., et al. Outcome of total parathyroidectomy and autotransplantation as treatment of secondary and tertiary hyperparathyroidism in children and adults. World J Surg 2010, 34(5):993-1000.
158. Iqbal C.W., Wahoff D.C. Diagnosis and management of pediatric endocrine neoplasms. Curr Opin Pediatr 2009, 21(3):379-385.
159. Durkin E.T., Nichol P.F., Lund D.P., et al. What is the optimal treatment for children with primary hyperparathyroidism?. Pediatrics 2009.
160. Pandit R.J., Innes W.A., Strong N.P., et al. Loss of vision?. Clear as crystal! Lancet 2010, 375(9714):610.
161. Shin S.H., Holmes H., Bao R., et al. Outpatient minimally invasive parathyroidectomy is safe for elderly patients. J Am Coll Surg 2009, 208(6):1071-1076.
162. Norenstedt S., Ekbom A., Brandt L., et al. Postoperative mortality in parathyroid surgery in Sweden during five decades: improved outcome despite older patients. Eur J Endocrinol 2009, 160(2):295-299.
163. Beus K.S., Stack B.C. Synchronous thyroid pathology in patients presenting with primary hyperparathyroidism. Am J Otolaryngol 2004, 25(5):308-312.
164. Sidhu S., Campbell P. Thyroid pathology associated with primary hyperparathyroidism. Aust N Z J Surg 2000, 70(4):285-287.
165. Bentrem D.J., Angelos P., Talamonti M.S., et al. Is preoperative investigation of the thyroid justified in patients undergoing parathyroidectomy for hyperparathyroidism?. Thyroidology 2002, 12(12):1109-1112.
166. Hollenbeak C.S., Lendel I., Beus K.S., et al. The cost of screening for synchronous thyroid disease in patients presenting with primary hyperparathyroidism. Arch Otolaryngol Head Neck Surg 2007, 133(10):1013-1021.
167. Wang T.S., Roman S.A., Cox H., et al. The management of thyroid nodules in patients with primary hyperparathyroidism. J Surg Res 2009, 154(2):317-323.
168. Sosa J.A., Powe N.R., Levine M.A., et al. Cost implications of different surgical management strategies for primary hyperparathyroidism. Surgery 1998, 124(6):1028-1035. Discussion 1035-26.
169. Snyder S.K., Lairmore T.C., Hendricks J.C., et al. Elucidating mechanisms of recurrent laryngeal nerve injury during thyroidectomy and parathyroidectomy. J Am Coll Surg 2008, 206(1):123-130.
170. Serpell J.W., Yeung M.J., Grodski S. The motor fibers of the recurrent laryngeal nerve are located in the anterior extralaryngeal branch. Ann Surg 2009, 249(4):648-652.
171. Laccourreye O., Paczona R., Ageel M., et al. Intracordal autologous fat injection for aspiration after recurrent laryngeal nerve paralysis. Eur Arch Otorhinolaryngol 1999, 256(9):458-461.
172. Abbas G., Dubner S., Heller K.S. Re-operation for bleeding after thyroidectomy and parathyroidectomy. Head Neck 2001, 23(7):544-546.
173. Pothier D.D. The use of drains following thyroid and parathyroid surgery: a meta-analysis. J Laryngol Otol 2005, 119(9):669-671.
174. Yarbrough D.E., Thompson G.B., Kasperbauer J.L., et al. Intraoperative electromyographic monitoring of the recurrent laryngeal nerve in reoperative thyroid and parathyroid surgery. Surgery 2004, 136(6):1107-1115.
175. Angelos P. Recurrent laryngeal nerve monitoring: state of the art, ethical and legal issues. Surg Clin North Am 2009, 89(5):1157-1169.
176. Kandil E., Wassef S.N., Alabbas H., et al. Minimally invasive video-assisted thyroidectomy and parathyroidectomy with intraoperative recurrent laryngeal nerve monitoring. Int J Otolaryngol 2009, 2009:739-798.
177. Randolph G.W., Kobler J.B., Wilkins J. Recurrent laryngeal nerve identification and assessment during thyroid surgery: laryngeal palpation. World J Surg 2004, 28(8):755-760.
178. Dralle H., Sekulla C., Lorenz K., et al. Intraoperative monitoring of the recurrent laryngeal nerve in thyroid surgery. World J Surg 2008, 32(7):1358-1366.
179. Harrison B.J., Triponez F. Intraoperative adjuncts in surgery for primary hyperparathyroidism. Langenbecks Arch Surg 2009, 394(5):799-809.
180. Horne S.K., Gal T.J., Brennan J.A. Prevalence and patterns of intraoperative nerve monitoring for thyroidectomy. Otolaryngol Head Neck Surg 2007, 136(6):952-956.
181. Sturgeon C., Sturgeon T., Angelos P. Neuromonitoring in thyroid surgery: attitudes, usage patterns, and predictors of use among endocrine surgeons. World J Surg 2009, 33(3):417-425.
182. Kern K.A. Medicolegal analysis of errors in diagnosis and treatment of surgical endocrine disease. Surgery 1993, 114(6):1167-1173. Discussion 1173-64.
183. Bekis R., Celik P., Uysal B., et al. Exposure of surgical staff in surgical probe applications in radioguided parathyroidectomy. Eur Arch Otorhinolaryngol 2008, 265(12):1545-1548.
184. Flynn M.B., Bumpous J.M., Schill K., et al. Minimally invasive radioguided parathyroidectomy. J Am Coll Surg 2000, 191(1):24-31.
185. Harris B., Bailey D., Roach P., et al. Use of fusion imaging to localize an ectopic thoracic parathyroid adenoma. Ann Thorac Surg 2006, 82(2):719-721.
186. Ramakrishna G., Miller T.D. Significant breast uptake of Tc-99m sestamibi in an actively lactating woman during SPECT myocardial perfusion imaging. J Nucl Cardiol 2004, 11(2):222-223.
187. Harman C.R., Grant C.S., Hay I.D., et al. Indications, technique, and efficacy of alcohol injection of enlarged parathyroid glands in patients with primary hyperparathyroidism. Surgery 1998, 124(6):1011-1019. Discussion 1019-20.
188. Veldman M.W., Reading C.C., Farrell M.A., et al. Percutaneous parathyroid ethanol ablation in patients with multiple endocrine neoplasia type 1. AJR Am J Roentgenol 2008, 191(6):1740-1744.
189. Tan C.C., Cheah W.K., Tan C.T., et al. Intramuscular injection of parathyroid autografts is a viable option after total parathyroidectomy. World J Surg 2010, 34(6):1332-1336.
190. Berger A.D., Wu W., Eisner B.H., et al. Patients with primary hyperparathyroidism-why do some form stones?. J Urol 2009, 181(5):2141-2145.
191. Peacock M., Bilezikian J.P., Klassen P.S., et al. Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism. J Clin Endocrinol Metab 2005, 90(1):135-141.
192. Peacock M., Bolognese M.A., Borofsky M., et al. Cinacalcet treatment of primary hyperparathyroidism: biochemical and bone densitometric outcomes in a five-year study. J Clin Endocrinol Metab 2009, 94(12):4860-4867.
193. Khan A., Grey A., Shoback D. Medical management of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab 2009, 94(2):373-381.
194. Khaleeli A.A., Johnson J.N., Taylor W.H. Prevalence of glucose intolerance in primary hyperparathyroidism and the benefit of parathyroidectomy. Diabetes/Metab Res Rev 2007, 23(1):43-48.
195. Untch B.R., Barfield M.E., Dar M., et al. Impact of 25-hydroxyvitamin D deficiency on perioperative parathyroid hormone kinetics and results in patients with primary hyperparathyroidism. Surgery 2007, 142(6):1022-1026.
196. Adler J.T., Sippel R.S., Chen H. Twenty-five-hydroxyvitamin D status does not affect intraoperative parathyroid hormone dynamics in patients with primary hyperparathyroidism. Ann Surg Oncol 2010.
197. Grubbs E.G., Rafeeq S., Jimenez C., et al. Preoperative vitamin D replacement therapy in primary hyperparathyroidism: safe and beneficial?. Surgery 2008, 144(6):852-858. Discussion 858-9.
198. Bradwell A.R., Harvey T.C. Control of hypercalcaemia of parathyroid carcinoma by immunisation. Lancet 1999, 353(9150):370-373.
199. Horie I., Ando T., Inokuchi N., et al. First Japanese patient treated with parathyroid hormone peptide immunization for refractory hypercalcemia caused by metastatic parathyroid carcinoma. Endocr J 2010, 57(4):287-292.
200. Winer K.K., Sinaii N., Reynolds J., et al. Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1-34 versus calcitriol and calcium. J Clin Endocrinol Metab 2010, 95(6):2680-2688.
201. Woods Ignatoski KM, Bingham EL, Doherty GM. Differentiating human stem cells into parathyroid for treatment of hypoparathyroidism. Paper Presented at: American Association of Endocrine Surgeons 2010, Pittsburgh, PA.